Biotech Company Achoagen Taps Latham for $72 Million IPO

, The Recorder

   | 0 Comments

SAN FRANCISCO — Achoagen, a South San Francisco-based biopharmaceutical company, tapped a team from Latham & Watkins for counsel on its $72 million initial public offering. A team from Davis Polk advised the underwriters.

What's being said

Comments are not moderated. To report offensive comments, click here.

Preparing comment abuse report for Article# 1202646854857

Thank you!

This article's comments will be reviewed.